NRIX NASDAQ
Nurix Therapeutics, Inc.
1W: +9.6%
1M: +5.4%
3M: +11.1%
YTD: -2.9%
1Y: +72.9%
3Y: +78.3%
5Y: -32.5%
$17.50
-0.03 (-0.17%)
Weekly Expected Move ±4.3%
$14
$15
$16
$17
$17
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$72M
Revenue
+27.2% YoY
$-295M
Net Income
-41.7% YoY
$-272M
Free Cash Flow
-34.9% YoY
-1245.8%
Gross Margin
-1479.4%
Op. Margin
-1394.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-55.4%
ROA-43.5%
ROIC-16216.4%
Valuation
P/E-6.5
P/B4.0
EV/EBITDA-4.2
Leverage
Debt/Equity0.10
Current Ratio7.02
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z4.57
Beneish M-4.69